Form 4 for RNXT RenovoRx, Inc.

Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-26 · accession 0001493152-24-004368 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-30	2024-01-26	RNXT	Bagai Shaun	CEO, Dir	P - Purchase	—	+41.0K	292.5K	+16%	—
D	2024-01-30	2024-01-26	RNXT	Bagai Shaun	CEO, Dir	P - Purchase	—	+41.0K	41.0K	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-26	P	A	40,983	—	292,540	D	—	—	(F1) Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.
2	Derivative	Warrants	2024-01-26	P	A	40,983	—	40,983	D	$1.22 · — to —	40,983 Common Stock	(F1) Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.